REP PROTEIN AS A PROTEIN ANTIGEN FOR USE IN DIAGNOSTIC DETERMINATIONS
CY1125860T1Undetermined Publication Date: 2026-04-17DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG STIFTUNG DES
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100111T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-10-10
- Filing Date
- 2023-03-01
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2043-03-01
Abstract
A DMA replication-associated protein (Rep) for multiple sclerosis (MS) is described, wherein (a) an increased amount of Rep protein or fragments thereof in a sample from a subject compared to an amount in a control sample or an increased amount of anti-Rep protein antibodies to antigen in a sample from a subject compared to an amount in a control sample is associated with a diagnosis of MS, wherein the Rep protein is an MSBI1 Rep or MSBI2 Rep.
Need to check novelty before this filing date? Find Prior Art